The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
In severely ill COVID-19 patients, TE complications were common, and patients with DVT, PE, stroke, or MI faced increased mortality, even with thromboprophylaxis. Age, obesity, elevated D-Dimer levels, and longer ICU stays were significant predictors of TE events. Considering these findings, a more aggressive approach, combining thromboprophylaxis with enhanced anti-inflammatory treatments, may be necessary for high-risk COVID-19 ICU patients to reduce TE events and mortality.
Authors
- Elizabeth K. Seng (ORCID: https://orcid.org/0000-0002-8938-4949)
- Hanis Hanum Zulkifly (ORCID: https://orcid.org/0000-0002-8474-7317)
- Long Chiau Ming (ORCID: https://orcid.org/0000-0002-6971-1383)
- Khang Wen Goh (ORCID: https://orcid.org/0000-0001-6686-7019)
- Nur Farhani Mansor
- Izzati Abdul Halim Zaki (ORCID: https://orcid.org/0000-0002-0066-5921)
- Mohan Pathmanathan
- Lee Chew Kiok
- Pakhrur Razi
- Tharmini Ravi
Institutions
- INTI International University (MY)
- National Institutes of Health (US)
- State University of Padang (ID)
- Hospital Kuala Lumpur (MY)
- Datta Meghe Institute of Higher Education and Research (IN)
- Hospital Sungai Buloh (MY)
- Universiti Teknologi MARA (MY)
- Sunway University (MY)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1080/20523211.2024.2449044
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00